A Large-scale Longitudinal Oncology Platform
The 'Personalize My treatment' (PMT) platform is a novel form of biobanking in which cancer
patients willingly consent to provide residual, clinical samples (surplus after diagnostic
testing) of their tumours for cancer research, to give access to their medical record for
data collection and then followed prospectively throughout the trajectory of their illness.
They further willingly consent to be recontacted for being informed of other research
projects, including clinical trials.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society